How Medical Device Trials Can Benefit from Decentralized Methods
At Castor, we hope to see DCT extend into all trials as we work alongside researchers in the pursuit of the ultimate goal of democratized clinical research.
Castor Expands Executive Leadership Team to Scale Clinical Trial Platform Technology
announced two executive appointments to accelerate the company’s growth and impact on the industry. Kimberly Tableman as Chief Clinical Development Officer (CCDO) and Anna Wozniak as Chief Financial & Development Officer (CFDO).
The evolution of eConsent
Since it was first instituted in the 1960s, written consent to participate in research studies has undergone very little change other than tightening regulations and increased participant education of their rights.
8 Data Types to Collect Remotely
Decentralized clinical trials (DCT) are collecting many kinds of data remotely, and this data is only expected to grow in volume. From wireless patches monitoring vitals to an ever-growing list of mobile-connected products, there are new data sources popping up almost everywhere.
Using Remote Image Capture eCOA for Hybrid Dermatology Trials
Learn how a remote-first approach to dermatology trials can streamline enrollment, increase patient retention, and ensure data quality.
What is eConsent?
eConsent accelerates enrollment, increases retention, and reduces site burden. Find out why it’s the way of the future for clinical trials here.
Case Study: COVID-RED Uses Castor’s Decentralized eClinical Platform
Download this case study to learn how Castor responded to the disruptive impact of COVID-19 and helped the COVID-RED study implement decentralized clinical trial methods to recruit over 17,825 participants in just 15 weeks.
Castor Leads Next-Gen Clinical Trials that Support Digital Therapeutics
Castor’s new eConsent platform will improve remote patient recruitment and enrollment as well as access to diverse populations by decentralizing clinical trials.
Developing an Infrastructure for Patient-Centric Decentralized Trials
Castor and Lightship discuss the infrastructure needs for providing the best patient experience and ensuring data integrity in decentralized clinical trials.